Sonic HealthcareSKHCF 68 Gross Margin % is 83.19% as of Dec. 2025, which is 1% below its 10-year median of 83.61. GuruFocus rates SKHCF with a GF Score™ of 68/100 and a GF Value™ of $20.60 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Sonic Healthcare ranks better than 90.72% on this metric.
The historical rank and industry rank for Sonic Healthcare's Gross Margin % or its related term are showing as below:
SKHCF'
s Gross Margin % Range Over the Past 10 Years
Min: 81.53 Med: 83.61 Max: 84.29
Current: 83.4
During the past 13 years, the highestGross Margin % of Sonic Healthcare was 84.29%. The lowest was 81.53%. And the median was 83.61%.
SKHCF's Gross Margin % is ranked better than 90.72% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.45
vs SKHCF: 83.40
Sonic Healthcare had a gross margin of 83.19% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sonic Healthcare was 0.30% per year.
Sonic Healthcare (OTCPK:SKHCF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sonic Healthcare had a gross margin of 83.19% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sonic Healthcare Gross Margin % Related Terms
Sonic Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sonic Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKHCF vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Sonic Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonic Healthcare Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sonic Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sonic Healthcare (SKHCF) has a Gross Margin % of 83.19% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Sonic Healthcare and its competitors. This is near median its historical median of 83.61. Over the past decade, Sonic Healthcare's Gross Margin % has ranged from 81.53 to 84.29. According to the industry distribution chart, Sonic Healthcare ranks #18 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 9.3%.
Is Sonic Healthcare's Gross Margin % too high?
Sonic Healthcare's current Gross Margin % of 83.19% is near median its 10-year median of 83.61. Over the past 10 years, this metric has ranged from a low of 81.53 to a high of 84.29. The Medical Diagnostics & Research industry median Gross Margin % is 50.45. Sonic Healthcare's value of 83.19% is 64.9% above this industry median. Based on the distribution chart, Sonic Healthcare ranks #18 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sonic Healthcare has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sonic Healthcare ranks #18 out of 194 companies for Gross Margin %. This places Sonic Healthcare in the top 9% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 50.45. Sonic Healthcare's value of 83.19% is 64.9% above this benchmark. Historically, Sonic Healthcare's own Gross Margin % has ranged from 81.53 to 84.29 over the past decade. While the company's 10-year median is 83.61 vs. the industry median of 50.45, Sonic Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonic Healthcare's current Gross Margin % of 83.19% is 64.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sonic Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonic Healthcare's current Gross Margin % is 83.19%, which is near median its own 10-year median of 83.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (SKHCF) is currently considered Significantly Undervalued. The stock's GF Value™ is $20.60, compared to a current price of $12.76 — trading 38.1% below its estimated fair value. The current Gross Margin % is 83.19%, which is near median its 10-year median of 83.61 and 64.9% above the Medical Diagnostics & Research industry median of 50.45. Sonic Healthcare's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sonic Healthcare (SKHCF), the current Gross Margin % is 83.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonic Healthcare (SKHCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued.
The current stock price of $12.76 is trading 38.1% below its estimated GF Value™ of $20.60.
GuruFocus considers Sonic Healthcare to be Significantly Undervalued.
Key valuation signals for SKHCF:
Gross Margin %: 83.19% (near median its 10-year median of 83.61)
GF Value™: $20.60 vs. price of $12.76 (38.1% below fair value)
Industry Position: 64.9% above the Medical Diagnostics & Research median (#18 of 194)
No single metric tells the full story. See the SKHCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
68GF Score
Get the complete analysis for SKHCF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKHCF has been successfully added to your 
